{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:15:29Z","timestamp":1792858529614,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-79340-z","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T14:48:48Z","timestamp":1732718928000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development of an efficient NUPR1 inhibitor with anticancer activity"],"prefix":"10.1038","volume":"14","author":[{"given":"Xi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Jimenez-Alesanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Rizzuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Neira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mat\u00edas","family":"Estaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Chuluyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Garona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florencia","family":"Gottardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Velazquez-Campoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Abian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Santofimia-Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Iovanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"79340_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"79340_CR2","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.3748\/wjg.v28.i32.4698","volume":"28","author":"I Ilic","year":"2022","unstructured":"Ilic, I. & Ilic, M. International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: A joinpoint regression analysis. World J. Gastroenterol. 28, 4698\u20134715 (2022).","journal-title":"World J. Gastroenterol."},{"key":"79340_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"79340_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41392-021-00659-4","volume":"6","author":"S Wang","year":"2021","unstructured":"Wang, S. et al. The molecular biology of pancreatic adenocarcinoma: Translational challenges and clinical perspectives. Signal Transduct. Target Ther. 6, 249 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"79340_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrclinonc.2013.66","volume":"10","author":"J Werner","year":"2013","unstructured":"Werner, J. et al. Advanced-stage pancreatic cancer: Therapy options. Nat. Rev. Clin. Oncol. 10, 323\u2013333 (2013).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"79340_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.4251\/wjgo.v12.i3.332","volume":"12","author":"A Vienot","year":"2020","unstructured":"Vienot, A. et al. FOLFOXIRI vs FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort study. World J. Gastrointest. Oncol. 12, 332\u2013346 (2020).","journal-title":"World J. Gastrointest. Oncol."},{"key":"79340_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejca.2021.03.040","volume":"151","author":"JM Riedl","year":"2021","unstructured":"Riedl, J. M. et al. Gemcitabine\/nab-paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis. Eur. J. Cancer 151, 3\u201313 (2021).","journal-title":"Eur. J. Cancer"},{"key":"79340_CR8","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1002\/jcp.22324","volume":"226","author":"CE Cano","year":"2011","unstructured":"Cano, C. E., Hamidi, T., Sandi, M. J. & Iovanna, J. L. Nupr1: The swiss-knife of cancer. J. Cell Physiol. 226, 1439\u20131443 (2011).","journal-title":"J. Cell Physiol."},{"key":"79340_CR9","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1074\/jbc.R109.080887","volume":"285","author":"S Goruppi","year":"2010","unstructured":"Goruppi, S. & Iovanna, J. L. Stress-inducible protein p8 is involved in several physiological and pathological processes. J. Biol. Chem. 285, 1577\u20131581 (2010).","journal-title":"J. Biol. Chem."},{"key":"79340_CR10","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00018-019-03347-3","volume":"77","author":"P Santofimia-Casta\u00f1o","year":"2020","unstructured":"Santofimia-Casta\u00f1o, P. et al. Targeting intrinsically disordered proteins involved in cancer. Cell Mol. Life Sci. 77, 1695\u20131707 (2020).","journal-title":"Cell Mol. Life Sci."},{"key":"79340_CR11","first-page":"309","volume":"7","author":"SB Su","year":"2001","unstructured":"Su, S. B. et al. Expression of p8 in human pancreatic cancer. Clin. Cancer Res. 7, 309\u2013313 (2001).","journal-title":"Clin. Cancer Res."},{"key":"79340_CR12","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1002\/jcp.22702","volume":"226","author":"MJ Sandi","year":"2011","unstructured":"Sandi, M. J. et al. p8 expression controls pancreatic cancer cell migration, invasion, adhesion, and tumorigenesis. J. Cell Physiol. 226, 3442\u20133451 (2011).","journal-title":"J. Cell Physiol."},{"key":"79340_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.tibtech.2006.07.005","volume":"24","author":"Y Cheng","year":"2006","unstructured":"Cheng, Y. et al. Rational drug design via intrinsically disordered protein. Trends Biotechnol. 24, 435\u2013442 (2006).","journal-title":"Trends Biotechnol."},{"key":"79340_CR14","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.coph.2010.09.005","volume":"10","author":"AK Dunker","year":"2010","unstructured":"Dunker, A. K. & Uversky, V. N. Drugs for \u2018protein clouds\u2019: Targeting intrinsically disordered transcription factors. Curr. Opin. Pharmacol. 10, 782\u2013788 (2010).","journal-title":"Curr. Opin. Pharmacol."},{"key":"79340_CR15","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1517\/17460441.2012.686489","volume":"7","author":"VN Uversky","year":"2012","unstructured":"Uversky, V. N. Intrinsically disordered proteins and novel strategies for drug discovery. Expert. Opin. Drug Discov. 7, 475\u2013488 (2012).","journal-title":"Expert. Opin. Drug Discov."},{"key":"79340_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.drudis.2018.09.017","volume":"24","author":"H Ruan","year":"2019","unstructured":"Ruan, H., Sun, Q., Zhang, W., Liu, Y. & Lai, L. Targeting intrinsically disordered proteins at the edge of chaos. Drug Discov. Today 24, 217\u2013227 (2019).","journal-title":"Drug Discov. Today"},{"key":"79340_CR17","doi-asserted-by":"publisher","first-page":"39732","DOI":"10.1038\/srep39732","volume":"7","author":"JL Neira","year":"2017","unstructured":"Neira, J. L. et al. Identification of a drug targeting an intrinsically disordered protein involved in pancreatic adenocarcinoma. Sci. Rep. 7, 39732 (2017).","journal-title":"Sci. Rep."},{"key":"79340_CR18","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1172\/JCI127223","volume":"129","author":"P Santofimia-Casta\u00f1o","year":"2019","unstructured":"Santofimia-Casta\u00f1o, P. et al. Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis. J. Clin. Invest. 129, 2500\u20132513 (2019).","journal-title":"J. Clin. Invest."},{"key":"79340_CR19","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.3390\/biom11101453","volume":"11","author":"B Rizzuti","year":"2021","unstructured":"Rizzuti, B. et al. Design of inhibitors of the intrinsically disordered protein NUPR1: Balance between drug affinity and target function. Biomolecules 11, 1453 (2021).","journal-title":"Biomolecules"},{"key":"79340_CR20","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1124\/jpet.104.080853","volume":"313","author":"S-Y Choi","year":"2005","unstructured":"Choi, S.-Y., Koh, Y.-S. & Jo, S.-H. Inhibition of human ether-a-go-go-related gene K+ channel and IKr of guinea pig cardiomyocytes by antipsychotic drug trifluoperazine. J. Pharmacol. Exp. Ther. 313, 888\u2013895 (2005).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"79340_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nrd1108","volume":"2","author":"B Fermini","year":"2003","unstructured":"Fermini, B. & Fossa, A. A. The impact of drug-induced QT interval prolongation on drug discovery and development. Nat. Rev. Drug Discov. 2, 439\u2013447 (2003).","journal-title":"Nat. Rev. Drug Discov."},{"key":"79340_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrd.2015.34","volume":"15","author":"G Gintant","year":"2016","unstructured":"Gintant, G., Sager, P. T. & Stockbridge, N. Evolution of strategies to improve preclinical cardiac safety testing. Nat. Rev. Drug Discov. 15, 457\u2013471 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"79340_CR23","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/med.21445","volume":"38","author":"S Kalyaanamoorthy","year":"2018","unstructured":"Kalyaanamoorthy, S. & Barakat, K. H. Development of safe drugs: The hERG challenge. Med. Res. Rev. 38, 525\u2013555 (2018).","journal-title":"Med. Res. Rev."},{"key":"79340_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112290","volume":"195","author":"A Garrido","year":"2020","unstructured":"Garrido, A., Lepailleur, A., Mignani, S. M., Dallemagne, P. & Rochais, C. hERG toxicity assessment: Useful guidelines for drug design. Eur. J. Med. Chem. 195, 112290 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"79340_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0008-6363(00)00119-X","volume":"47","author":"W Haverkamp","year":"2000","unstructured":"Haverkamp, W. et al. The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: Clinical and regulatory implications. Report on a policy conference of the European society of cardiology. Cardiovasc. Res. 47, 219\u2013233 (2000).","journal-title":"Cardiovasc. Res."},{"key":"79340_CR26","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.3390\/ijms20061324","volume":"20","author":"RM Lester","year":"2019","unstructured":"Lester, R. M., Paglialunga, S. & Johnson, I. A. QT Assessment in early drug development: The long and the short of it. Int. J. Mol. Sci. 20, 1324 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"79340_CR27","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1161\/CIRCRESAHA.112.268946","volume":"111","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi, L., Kepp, O., Trojel-Hansen, C. & Kroemer, G. Mitochondrial control of cellular life, stress, and death. Circ. Res. 111, 1198\u20131207 (2012).","journal-title":"Circ. Res."},{"key":"79340_CR28","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s42003-022-03705-1","volume":"5","author":"P Santofimia-Casta\u00f1o","year":"2022","unstructured":"Santofimia-Casta\u00f1o, P. et al. NUPR1 protects against hyperPARylation-dependent cell death. Commun. Biol. 5, 732 (2022).","journal-title":"Commun. Biol."},{"key":"79340_CR29","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.3390\/cells8111453","volume":"8","author":"P Santofimia-Casta\u00f1o","year":"2019","unstructured":"Santofimia-Casta\u00f1o, P. et al. Targeting the stress-induced protein NUPR1 to treat pancreatic adenocarcinoma. Cells 8, 1453 (2019).","journal-title":"Cells"},{"key":"79340_CR30","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.bbagen.2018.03.009","volume":"1862","author":"P Santofimia-Casta\u00f1o","year":"2018","unstructured":"Santofimia-Casta\u00f1o, P. et al. Amphipathic helical peptides hamper protein-protein interactions of the intrinsically disordered chromatin nuclear protein 1 (NUPR1). Biochimica et Biophysica Acta BBA General Subjects 1862, 1283\u20131295 (2018).","journal-title":"Biochimica et Biophysica Acta BBA General Subjects"},{"key":"79340_CR31","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791 (2009).","journal-title":"J. Comput. Chem."},{"key":"79340_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"79340_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2022.140757","volume":"1870","author":"B Rizzuti","year":"2022","unstructured":"Rizzuti, B. Molecular simulations of proteins: From simplified physical interactions to complex biological phenomena. Biochim. Biophys. Acta Proteins Proteom. 1870, 140757 (2022).","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"79340_CR34","doi-asserted-by":"publisher","first-page":"32360","DOI":"10.1074\/jbc.272.51.32360","volume":"272","author":"GV Mallo","year":"1997","unstructured":"Mallo, G. V. et al. Cloning and expression of the rat p8 cDNA, a new gene activated in pancreas during the acute phase of pancreatitis, pancreatic development, and regeneration, and which promotes cellular growth. J. Biol. Chem. 272, 32360\u201332369 (1997).","journal-title":"J. Biol. Chem."},{"key":"79340_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216464","volume":"579","author":"C Wang","year":"2023","unstructured":"Wang, C. et al. SETD4 inhibits prostate cancer development by promoting H3K27me3-mediated NUPR1 transcriptional repression and cell cycle arrest. Cancer Lett. 579, 216464 (2023).","journal-title":"Cancer Lett."},{"key":"79340_CR36","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41467-021-20904-2","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. NUPR1 is a critical repressor of ferroptosis. Nat. Commun. 12, 647 (2021).","journal-title":"Nat. Commun."},{"key":"79340_CR37","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1002\/art.38391","volume":"66","author":"RR Yammani","year":"2014","unstructured":"Yammani, R. R. & Loeser, R. F. Brief report: Stress-inducible nuclear protein 1 regulates matrix metalloproteinase 13 expression in human articular chondrocytes. Arthritis Rheumatol. 66, 1266\u20131271 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"79340_CR38","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1074\/jbc.M008594200","volume":"276","author":"JA Encinar","year":"2001","unstructured":"Encinar, J. A. et al. Human p8 is a HMG-I\/Y-like protein with DNA binding activity enhanced by phosphorylation. J. Biol. Chem. 276, 2742\u20132751 (2001).","journal-title":"J. Biol. Chem."},{"key":"79340_CR39","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3390\/biom10091313","volume":"10","author":"JL Neira","year":"2020","unstructured":"Neira, J. L. et al. A phosphorylation-induced switch in the nuclear localization sequence of the intrinsically disordered NUPR1 hampers binding to importin. Biomolecules 10, 1313 (2020).","journal-title":"Biomolecules"},{"key":"79340_CR40","doi-asserted-by":"publisher","first-page":"E6332","DOI":"10.1073\/pnas.1619932114","volume":"114","author":"P Santofimia-Casta\u00f1o","year":"2017","unstructured":"Santofimia-Casta\u00f1o, P. et al. Intrinsically disordered chromatin protein NUPR1 binds to the C-terminal region of Polycomb RING1B. Proc. Natl. Acad. Sci. 114, E6332\u2013E6341 (2017).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"79340_CR41","doi-asserted-by":"crossref","unstructured":"Bastos, M. et al. Isothermal titration calorimetry. Nat. Rev. Methods Prim 3 (2023).","DOI":"10.1038\/s43586-023-00199-x"},{"key":"79340_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078101","volume":"8","author":"D Aguado-Llera","year":"2013","unstructured":"Aguado-Llera, D. et al. Deciphering the binding between Nupr1 and MSL1 and their DNA-repairing activity. PLoS One 8, e78101 (2013).","journal-title":"PLoS One"},{"key":"79340_CR43","doi-asserted-by":"publisher","first-page":"16999","DOI":"10.1038\/s41598-018-35020-3","volume":"8","author":"P Santofimia-Casta\u00f1o","year":"2018","unstructured":"Santofimia-Casta\u00f1o, P. et al. Inactivation of NUPR1 promotes cell death by coupling ER-stress responses with necrosis. Sci. Rep. 8, 16999 (2018).","journal-title":"Sci. Rep."},{"key":"79340_CR44","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.annonc.2020.10.601","volume":"32","author":"R Nicolle","year":"2021","unstructured":"Nicolle, R. et al. A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma. Ann. Oncol. 32, 250\u2013260 (2021).","journal-title":"Ann. Oncol."},{"key":"79340_CR45","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt, J., Santos-Martins, D., Tillack, A. F. & Forli, S. AutoDock Vina 1.2.0: New docking methods, expanded force field, and python bindings. J. Chem. Inform. Model. 61, 3891\u20133898 (2021).","journal-title":"J. Chem. Inform. Model."},{"key":"79340_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-4-17","volume":"4","author":"MD Hanwell","year":"2012","unstructured":"Hanwell, M. D. et al. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J. Cheminform. 4, 1\u201317 (2012).","journal-title":"J. Cheminform."},{"key":"79340_CR47","doi-asserted-by":"publisher","first-page":"bbac201","DOI":"10.1093\/bib\/bbac201","volume":"23","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. fastDRH: A webserver to predict and analyze protein-ligand complexes based on molecular docking and MM\/PB(GB)SA computation. Brief Bioinform 23, bbac201 (2022).","journal-title":"Brief Bioinform"},{"key":"79340_CR48","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","volume":"16","author":"C Tian","year":"2020","unstructured":"Tian, C. et al. ff19SB: Amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J. Chem. Theory Comput. 16, 528\u2013552 (2020).","journal-title":"J. Chem. Theory Comput."},{"key":"79340_CR49","doi-asserted-by":"publisher","DOI":"10.1063\/5.0019056","volume":"153","author":"X He","year":"2020","unstructured":"He, X., Man, V. H., Yang, W., Lee, T.-S. & Wang, J. A fast and high-quality charge model for the next generation general AMBER force field. J. Chem. Phys. 153, 114502 (2020).","journal-title":"J. Chem. Phys."},{"key":"79340_CR50","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1021\/jz501780a","volume":"5","author":"S Izadi","year":"2014","unstructured":"Izadi, S., Anandakrishnan, R. & Onufriev, A. V. Building water models: A different approach. J. Phys. Chem. Lett. 5, 3863\u20133871 (2014).","journal-title":"J. Phys. Chem. Lett."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79340-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79340-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79340-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T16:17:47Z","timestamp":1732724267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79340-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["79340"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-79340-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]},"assertion":[{"value":"5 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal care and experimental procedures were performed in agreement with the Animal Ethics Committee of Marseille number 14 (C2EA-14). Approval Number: 202011181636926.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"29515"}}